Advertisement
Merry Xmas NIH—Here's your 0.1% additional raise

Merry Xmas NIH—Here's your 0.1% additional raise

By Merrill Goozner  |  December 13, 2016

The 21st Century Cures Act signed by President Obama Tuesday has been ballyhooed as a major boost for NIH and cancer and brain research. But a closer look at the numbers reveals how little it offers—at a potentially high price.

Vital Signs: Who will lead FDA under Trump?

By Adam Rubenfire  |  December 08, 2016

Rumors are swirling about who President-elect Donald Trump may choose to lead the Food and Drug Administration, including a venture capitalist and a former agency official.

Advocates cheer mental health reforms in 21st Century Cures Act bill

Advocates cheer mental health reforms in 21st Century Cures Act bill

By Harris Meyer  |  December 03, 2016

Congress took an important first step in improving the nation's struggling system of care for millions of Americans suffering from mental illness and drug addiction by including a sweeping package of mental healthcare and addiction treatment reforms as part of the 21st Century Cures Act.

Editorial: The 21st Century Christmas Tree Act

Editorial: The 21st Century Christmas Tree Act

By Merrill Goozner  |  December 03, 2016

On the surface, it looks like every healthcare special interest and their 1,400 lobbyists won an early Christmas present courtesy of the 21st Century Cures Act, which passed the House of Representatives by a whopping 392-26 margin last week and appears headed for Senate passage and enactment.

Add-ons assure Cures Act easy lame-duck passage

Add-ons assure Cures Act easy lame-duck passage

By Shannon Muchmore  |  December 03, 2016

The 21st Century Cures Act last week received cheers from virtually every segment of the healthcare industry. The bill appears headed for quick Senate passage and signature into law by President Barack Obama.

Controversial changes coming to FDA

By Adam Rubenfire and Shannon Muchmore  |  December 03, 2016

The 21st Century Cures Act, which overwhelmingly passed the House last week, opens new avenues for companies to win quicker FDA approval. It continues to draw fire from safety advocates and worried payers, who foot the bill for expensive new therapies.

Cures Act blocks FDA's ability to regulate wellness apps and other health IT

Cures Act blocks FDA's ability to regulate wellness apps and other health IT

By Joseph Conn  |  December 02, 2016

The agency won't regulate software "for administrative support of a healthcare facility." That includes financial records, information about patient populations, and a number of consumer-facing applications, including those for “maintaining and encouraging a healthy lifestyle.”

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print